High-dose cyclophosphamide to treat severe aplastic anemia.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000741:Anemia, Aplastic / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000009:adverse effects; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D009504:Neutrophils; D017713:Platelet Transfusion; D011446:Prospective Studies; D012074:Remission Induction; D016019:Survival Analysis
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide